First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
Clinical trial NCT04974944 · TERMINATED
Trial details
- NCT number
- NCT04974944
- Sponsor
- Sun Yat-Sen University Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2024-01-08
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.